Cosmo Robotics , a wearable rehabilitation robot specialist, announced on the 16th that it had passed the technology evaluation for a KOSDAQ technology special listing on the 11th. Accordingly, the company has begun the listing process in earnest by preparing to apply for a preliminary listing review to the Korea Exchange.
This evaluation for the technology-specific listing was conducted by two professional evaluation agencies designated by the Korea Exchange, and Cosmo Robotics reportedly received high scores in both the technology and business viability categories.
Cosmo Robotics is a company with wearable robot technology specialized in the medical and rehabilitation fields, and its representative products include the 'Bambini' series of pediatric walking rehabilitation robots and adult walking assistance robots. It is currently diversifying its revenue structure by operating a rental and fee-based business model along with hospital deliveries.
The company is currently pursuing certification procedures and establishing distribution channels for global markets such as the US, Europe, Russia, and India, and plans to pursue expansion of government procurement and overseas market entry strategies in the future. Passing this technology evaluation is expected to secure funds for R&D investment and business expansion.
NH Investment & Securities and Eugene Investment & Securities are jointly handling the listing of Cosmo Robotics.
“Through this technology evaluation, we have received official external recognition for our technological prowess,” said Oh Ju-young, co-CEO of Cosmo Robotics. “We will continue to focus on technological advancement and overseas market expansion after going public.”
- See more related articles
You must be logged in to post a comment.